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Abstract Progesterone (P) has previously been shown to induce 
a rapid increase in [Ca2+]i as well as tyrosine pbosphorylation of 
proteins in human spermatozoa. Both these effects are essential 
for induction of the acrosome reaction by P. We investigated a
possible relationship between the P-induced calcium increase and 
tyrosine kinase activation, by evaluating the effect of the tyrosine 
kinase inhibitor genistein on these two effects. We found that 
preincubation with genistein abolished P-induced tyrosine phos- 
phorylation of two sperm proteins of 97 and 75 kDa molecular 
weight and significantly inhibited the plateau phase of P-induced 
[CaZ÷]i increase without affecting the peak phase. Conversely, the 
plateau phase was enhanced by the tyrosine phosphatase inhibitor 
Na3VO 4. The effect of genistein was specific for P, since no 
inhibition was observed on the [Ca2+]i increase induced by thapsi- 
gargin, an inhibitor of endoplasmic Ca2+-ATPase previously 
shown to mobilize Ca 2+ in spermatozoa. These results indicate 
that tyrosine kinase activation is involved in the generation of the 
plateau phase of Ca 2+ influx induced by P, and suggest he possi- 
bility that two different pathways are involved in the induction of 
Ca 2+ entry by P in human sperm. 
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1. Introduction 
The acrosome reaction of spermatozoa is a specialized exocy- 
totic event promoted by an increase in intracellular Ca 2+ essen- 
tial for the process of fertilization [1]. This irreversible r action 
occurs after interaction of the spermatozoon with the oocyte 
and consists of the fusion and fenestration of the outer acro- 
somal membrane with the plasma membrane, resulting in the 
release of acrosomal enzymes which aid the spermatozoon i  
penetrating the various investments of the oocyte [1]. Among 
the different stimuli of acrosome reaction, progesterone (P) is 
considered, together with zona pellucida proteins, to be one of 
the physiological inducers of this event, being present in high 
levels in the cumulus matrix that surrounds the oocyte [2]. P 
triggers calcium influx [3-5] in human spermatozoa bystimulat- 
ing a poorly characterized cell surface receptor [6], which ap- 
pears to be different from nuclear P receptors [5,7]. P-induced 
calcium waves are characterized by an initial transient peak 
followed by a sustained plateau phase lasting for several min- 
utes [4,5]. Both these effects are dependent on extracellular 
calcium since they do not occur when calcium is removed from 
the external medium [4]. In addition to an increase in calcium, 
P has been shown to promote tyrosine phosphorylation of
sperm proteins [8,9]. Such an effect is, at least partially, 
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involved in induction of the acrosome reaction, since inhibitors 
of tyrosine kinases blunted the exocytotic effect of P [8,9]. 
However, P-induced tyrosine phosphorylation of proteins is 
independent of extracellular calcium [8], raising the question of 
whether the increase in [Ca2+]~ stimulated by P. which is also 
essential for induction of the acrosome reaction of spermatozoa 
[10,11], could be downstream of tyrosine kinase activation, as 
recently demonstrated in other cell systems [12-15]. We have 
investigated the involvement of tyrosine kinase activity in the 
regulation of Ca 2+ entry induced by P, by studying the effect 
of the tyrosine kinase inhibitor genistein on tyrosine phospho- 
rylation of sperm proteins and on the increase in [Ca2+]~ stimu- 
lated by P. We found that tyrosine kinase inhibition signifi- 
cantly inhibits the plateau phase of Ca 2+ entry without affecting 
the rapid peak phase of the P-induced calcium response. 
2. Materials and methods 
2.1. Chemicals" 
Fura-2/AM, thapsigargin, free acid ionomycin, genistein and her- 
bimycin were purchased from Calbiochem (La Jolla, CA). Sodium 
orthovanadate (Na3VO4) , progesterone, fatty acid-free bovine serum 
albumin (BSA), gelatin, glycine, trizmabase, Temed, APS, o-phospho- 
DL-tyrosine, Ponceau S and Cooamassie R250, ethylene glycol-bis 
(fl-aminoethyl ether) tetraacetic acid (EGTA) were from Sigma (St. 
Louis, MO). Sangivamycin was obtained from National Institutes of 
Health Drug Synthesis and Chemistry Branch (Bethesda, MD). Perox- 
idase-conjugated monoclonal (PY 20) anti-phosphotyrosine a tibody 
was from 1CN (Costa Mesa, CA). Reagents for sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis were from Bio-Rad Labs 
(Hercules, CA). Protein molecular weight standards and Tween 20 were 
from Fluka Chemie AG (Bucks, Switzerland). Percoll was obtained 
from Pharmacia LKB (Uppsala, Sweden). Enhanced chemilumines- 
cence (ECL) Western blotting detection reagents were from Amher- 
sham (Buckinghamshire, UK). Sperm preparation medium (229.5 mg/1 
CaC12.2H20, 346.55 mg/l KC1, 173.27mg/1 MgSO4- 7H20, 5891.28 mg/1 
NaCI, 2200 mg/l NaHCO3, 137.15 rag/1 Na H2PO4-2H20, 866.36 mg/l 
o-glucose, 8.66 mg/l Phenol red, 97.0 mg/l Na-pyruvate, 1000 mg/l 
HEPES sodium salt, 3010 mg/1 HEPES acid, 1.0 ml/1 SSR2 (Comp. A), 
1.0 ml/1 SSr2 (Comp. B), 50 mg/ml streptomycin, 50,000 IU/I penicillin 
and 10 mg/ml human serum albumin) was obtained from M EDI-CU LT 
(Denmark). Genistein and herbimycin were dissolved in DMSO at the 
initial concentration f 10 mg/ml and further diluted in buffer. 
2.2. Preparation of spermatozoa 
Human semen was obtained from normospermic men undergoing 
semen analysis for couple infertility. Spermatozoa were washed from 
seminal plasma nd prepared by the swim-up rocedure as described 
previously [16]. In some xperiments, spermatozoa were separated on 
a Percoll gradient as described [5,17]. Sperm samples were capacitated 
for 2 h in sperm preparation medium at 37°C in an atmosphere of CO> 
Motility was evaluated using a fully automated computer-assisted 
semen analyzer (Hamilton-Thorn) [16]. 
2.3. Measurement of intracellular calcium concentration 
Spermatozoa, prepared as described above, were loaded with 2 gtM 
Fura 2/AM for 45 min at 37°C, washed, resuspended in FM medium 
(125 mmol/I NaCI, 10 mmol/l KC1, 2.5 CaCI 2, 0.25 mmol/1 MgCI2, 
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19 mM Na-lactate, 2.5 mM Na-pyruvate, 2 mM HEPES, 3 mg/ml BSA) 
and [Ca2+]~ measured as described previously using a spectrofluorimet- 
tic method [5,16]. Fura-2 loaded spermatozoa were preincubated for 
3 min with genistein, sangivamycin, Na3VO4 or control solvents, centri- 
fuged, resuspended in FM buffer and transferred to a quartz cuvette 
for calcium measurements a  aconcetration f 5 × 106 cells/ml. Sperma- 
tozoa were stimulated with 1 ~tg/ml P. Fluorescence measurements were 
converted to [Ca2+]i by determining maximal fluorescence (Fro,0 with 
ionomycin (8 mM final concentration) followed by minimal fluores- 
cence (Fmi,) with 10 mM EGTA, pH 10. [Ca2+]i was calculated accord- 
ing to Grynkiewicz et al. [18] assuming a dissociation constant of Fura 
2 for calcium of 224 nM. 
2.4. SDS-PAGE and Western blot analysis 
After incubation with P (1 Bg/ml) under the indicated conditions, the 
samples were processed for SDS-PAGE as described previously [9]. 
Briefly, samples were centrifuged at 400 × g at 4°C, washed in BSA-free 
medium, resuspended in 10/A lysis buffer Sb 2 × (62.5 mM Tris, pH 6.8, 
containing 10% glycerol, 20% SDS, 2.5% pyronin and 200 mM dithio- 
threitol), and incubated at 95°C for 5 min. After measurement of 
proteins, the suspension was loaded onto 7.5% polyacrilamide-bis- 
acrylamide gels, subjected to electrophoresis, transferred tonitrocellu- 
lose (Sigma, St. Louis, MO), and immunostained with peroxidase- 
conjugated monoclonal nti-phosphotyrosine a tibodies (PY20). The 
immunoreactions were revealed by the enhanced chemiluminescence 
system (ECL, Amersham). Quantification fthe bands was performed 
by image analysis as described previously [9]. 
2.5. Statistical analysis 
Data are expressed as mean + S.E.M. Differences between means 
were assessed by Student's t-test for paired data and P < 0.05 was 
considered as statistically significant. 
3. Results 
In a previous tudy, we reported that P induces an increase 
in tyrosine phosphorylation i two sperm protein bands, re- 
spectively of 75 and 97 kDa, and that this effect was inhibited 
by the tyrosine kinase inhibitor erbstatin [9]. Short term (5 min) 
preincubation of spermatozoa with 10/.tM genistein also pre- 
vented the increase in tyrosine phosphorylation i duced by P 
in these two bands (Fig. 1), confirming activation of tyrosine 
kinase(s) by the steroid. To investigate whether tyrosine kinase 
activation is involved in the [Ca2+]i increase induced by P, ca- 
pacitated spermatozoa were preincubated for 5 min with genis- 
tein (1 30/.tM) or control solvent. As shown in Fig. 2A and B, 
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Fig. 1. Effect of genistein (10/zM final concentration, 5 min preincuba- 
tion) on basal and progesterone-stimulated tyrosine phosphorylation 
of proteins in capacitated human spermatozoa. Tyrosine phosphoryl- 
ated proteins were revealed using the monoclonal nti-phosphotyrosine 
antibody PY20-HRP followed by the ECL detection system. Molecular 
weight markers (× 103) are indicated to the right of the blot. 
the addition of P to Fura 2-loaded spermatozoa from two 
different subjects induced an increase in [Ca2+]~ characterized 
by an initial transient peak and a long-lasting plateau phase. 
Pretreatment with increasing concentrations of genistein did 
not affect the Ca 2+ rise to a peak, but markedly decreased the 
plateau phase (Fig. 2A and B) at concentrations a  low as 1/zM. 
The average P-stimulated peak [Ca2+]i and plateau in 9 different 
subjects in the presence or absence of increasing concentrations 
of genistein are reported in Fig. 3A for the peak and Fig. 3B 
for the plateau. No significant effect of genistein was observed 
on the peak [Ca2+]~ at any concentration tested (Fig. 3A), 
whereas the inhibitory effect on the plateau phase was signifi- 
cant starting from 1/IM and was not further enhanced at higher 
genistein concentrations (Fig. 3B). The effect of genistein was 
specific for the P-induced sperm [Ca2+]i increase, since it did not 
affect the peak or the plateau phase of [Ca2+]i obtained follow- 
ing stimulation with the endoplasmic Ca~+-ATPase inhibitor 
thapsigargin (10 tiM), previously shown to increase [Ca2+]i [19] 
and the acrosome reaction [20] in human spermatozoa. Fig. 4 
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Fig. 2. Effect of progesterone (0.1 ,ug/ml final concentration) on [Ca2+], in Fura 2-loaded, capacitated human spermatozoa in basal conditions or 
following preincubation with increasing concentrations of genistein (G) in two different subjects (A and B). [Ca2+]~ was evaluated by a fluorimetric 
method as described in the text. The arrows indicate addition of progesterone. 
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shows the effect of l and l0 /~M genistein on Ca 2+ waves 
induced by 10 pM thapsigargin (panel A) or (for comparison) 
by 1/lg/ml P (panel B) in spermatozoa obtained from the same 
subject. The effect of genistein does not appear to be due to a 
toxic effect on spermatozoa, since motility parameters, evalu- 
ated by a fully automated motion analyzer (Hamilton-Thorn), 
were not affected by treatment with genistein (results not 
shown). Pretreatment with genistein did not affect basal [Ca2+]i, 
or response to ionomycin (data not shown). We also tested the 
effect of herbimycin A, an inhibitor of tyrosine kinase structur- 
ally unrelated to genistein, on the sperm [Ca2+]~ increase in- 
duced by P. A 3 rain preincubation with 30/,tM herbimycin A
did not affect the peak phase of the P-induced [Ca2+]i increase, 
but inhibited, although to a much lesser extent han genistein, 
the plateau phase (1.84+ 0.13 fold increase in control vs. 
1.52 + 0.08 fold increase in treated samples; % inhibition 
27.5 + 3.4; n -- 4, P < 0.05). Herbimycin A did not significantly 
affect basal [Ca2+]i nor response to ionomycin (data not shown). 
To confirm that the effects of genistein and herbimycin are not 
due to aspecific inhibition of protein kinase C, we evaluated the 
effect of a short term (3 min) preincubation with the protein 
kinase C inhibitor sangivamycin. At a concentration of0.1 pM, 
sangivamycin did not affect the plateau or the peak phase of 
the [Ca2+]L increase induced by P (results not shown), indicating 
that the effect of genistein is not due to aspecific inhibition of 
protein kinase C. Conversely, the tyrosine phosphatase inhibi- 
tor Na3VO4 (0.1 raM, 3 rain preincubation), induced a signifi- 
cant increase in the plateau phase of [Ca2+]i induced by P with- 
out affecting the peak phase (Table 1) or basal [Ca2+]i (not 
shown). The average increase in the plateau phase induced by 
Na~VO4 was 1.32 + 0.05 fold over control (n -= 5). 
4. Discussion 
The rapid, non-genomic action of progesterone (P) on 
human spermatozoa has recently been identified [6]. Previous 
studies demonstrated that P induces an increase in [Ca2+]~ [3-5] 
as well as tyrosine phosphorylation of a protein in the 95 97 
kDa molecular weight range [8,9]. In the present study we show 
evidence that activation of tyrosine kinases by P is upstream of 
the generation of the sustained phase of the [Ca2+]i increase. 
Indeed, we have demonstrated that incubation with molar con- 
centrations of the tyrosine kinase inhibitor genistein strongly 
inhibited the plateau phase of the [Ca2*]~ increase induced by 
R In contrasL the peak phase of [Ca2+], in response to P was 
unaffected by this treatment. Moreover, preincubation with the 
tyrosine phosphatase inhibitor Na3VO 4 increases the plateau 
phase of the P response, further confirming the involvement of 
tyrosine kinase in this effect. Our results indicate that the 
Table 1 
Effect of protein tyrosine phosphatase inhibitor Na3VO4 on the peak 
and plateau phases of the [Ca2+]i increase induced by progesterone in
human spermatozoa 
Control Na3VO 4 
Peak [Ca2+]i 3.47 + 0.59 3.84 + 0.62 
Plateau [Ca2+]i 1.50 + 0.15 1.97 + 0.24* 
Fura 2-loaded spermatozoa were preincubated for 3 min with Na3VO4, 
centrifuged, and [Ca2÷]~ evaluated by a spectrofluorimetric method as 
described in the text. Data are expressed as fold increase over basal 
[Ca2+],. n = 5 experiments; *P < 0.05. 
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Fig. 3. Average peak [Ca2+]~ (panel A) and plateau phase (panel B) in 
response to progesterone in Fura 2-loaded, capacitated human sperma- 
tozoa under basal conditions or following preincubation with increas- 
ing concentrations ofgenistein. [Ca2+]~ was evaluated by a fluorimetric 
method as described in the text. 
P-mediated increase in tyrosine phosphorylation may be in- 
volved in opening a membrane calcium channel responsible for 
the plateau phase of [Ca2+]~ waves in response to P. Since the 
increase in tyrosine phosphorylation mediated by P is inde- 
pendent of extracellular calcium, and since both [Ca2+]i increase 
and tyrosine kinase activation are essential for induction of 
acrosome reaction [8-11], it is tempting to speculate that the 
plateau phase of the calcium increase could be more important 
than the peak phase in determining the increase in the acrosome 
reaction in response to R We have recently reported that an 
increase in calcium and the acrosome reaction in response to 
P are highly correlated, with the exception of few cases, with 
in vitro fertilization of human oocytes [16], indicating a func- 
tional relationship between sperm fertilizing ability and respon- 
siveness to P. In the light of present results, it would be interest- 
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ing to investigate whether a stricter correlation exists between 
the plateau phase of the calcium increase in response to P and 
in vitro fertilization outcome. 
The inhibitory effect of genistein on the P-induced [Ca2+]~ 
response in human sperm appears to be due to inhibition of 
P-stimulated tyrosine kinase activity. Indeed, we have shown 
that at similar concentrations genistein also inhibits the P-in- 
duced increase in tyrosine phosphorylation of sperm proteins, 
confirming previous results obtained with a different yrosine 
kinase inhibitor [9]. To control for non-specific effects of geni- 
stein, we employed the chemically and mechanistically dissimi- 
lar tyrosine kinase inhibitor herbimycin A. While herbimycin 
A is thought to inhibit PTK activity through benzoquinone 
interactions with protein sulfhydral groups, genistein is a com- 
petitive inhibitor with respect o ATR A slight but significant 
inhibitory effect on the plateau phase of the P response was also 
observed with herbimycin, further indicating that tyrosine ki- 
nase is involved in such an effect. Furthermore, genistein did 
not inhibit the sustained phase of Ca 2+ entry stimulated by the 
endoplasmic Ca-ATPase inhibitor thapsigargin, indicating that 
the effect of this agent is not due to aspecific inhibition of Ca 2+ 
entry. An inhibitory effect of genistein and other tyrosine ki- 
nase inhibitors of agonist-mediated calcium signaling has been 
shown in several other reports [12 15]. In these studies, the 
inhibitory effect of genistein has been observed either on the 
agonist- induced peak [Ca2+]~ increase, without affecting the 
plateau phase [13,15], as well as on the plateau phase without 
affecting the peak [12,14], with similar results to those obtained 
in our study. 
The mechanism of P-mediated stimulation of human sperma- 
tozoa is still unclear. Apparently, such action is not mediated 
by a genomic pathway, since the antagonist of nuclear P recep- 
tors RU486 does not inhibit P responses except at very high 
doses [21,22]. The presence of P binding sites in human sperm 
has been recently reported [23], however, a precise characteriza- 
tion of these receptors is still lacking. Our results suggest he 
possibility that the P-mediated sperm [Ca>]l increase is medi- 
ated by two different pathways, a first one responsible for the 
peak transient that apparently does not involve tyrosine kinase 
activation, and a second one, responsible for the long-lasting 
plateau phase, which appears to be partially mediated by P- 
induced tyrosine kinase activation. The fact that the thapsi- 
gargin-induced [Ca2+]i increase in human sperm is not inhibited 
by genistein suggests that P and thapsigargin induce calcium 
influx through different pathways. Indeed, we have evidence 
that thapsigargin does not activate tyrosine kinase(s) in human 
sperm (unpublished observation). 
In conclusion, we report evidence that tyrosine kinase activ- 
ity is, at least partially, involved in the P-induced sustained 
phase of the [Ca2+]i increase, providing new insights into the 
mechanisms of P-induced responses in human sperm. As re- 
cently stated, real progress in understanding male infertility, 
will only come 'if we attempt o understand more about how 
a spermatozoon is made and how it works' [24]. 
Acknowledgements: This work was supported by Consiglio Nazionale 
delle Ricerche (CNR, Rome, Targeted Project: FATMA, contract no. 
92.00097-PF41), Ministero dell'Universita' e della Ricerca Scientifica 
e Tecnologica (Rome) and Regione Toscana (Florence). We thank 
Prof. Mario Serio, Dr. Mario Maggi (Unita" di Endocrinologia, 
Universita' di Firenze), Dr. Paola Failli and Dr. Carlo Ruocco (Dipar- 
timento di Farmacologia, Universita' di Firenze) for valuable advice. 
A .-,= 
Z ~ O E.~. 
~1 lo~- 
B 
~ cont ro l  
2: 
Fig. 4. Sperm [Ca:+]~ increase in response to thapsigargin (10 ~M final 
concentration, panel A) and progesterone (1 pg/ml, panel B) under 
control conditions or following preincubation with 1 and 10/zM geni- 
stein (G). Representative of two similar experiments. 
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